Genistein and resveratrol: Mammary cancer chemoprevention and mechanisms of action in the rat

Expert Review of Anticancer Therapy

Volumn 6, Issue 12, 2006, Pages 1699-1706

  Whitsett Jr , Timothy G ^a   Lamartiniere, Coral A ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Chemoprevention; Genistein; Mammary cancer; Resveratrol

Indexed keywords

BRCA1 PROTEIN; CYCLOOXYGENASE 2; CYTOCHROME P450; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GELATINASE B; GENISTEIN; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RESVERATROL; SOYBEAN OIL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; DIET; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TREATMENT FAILURE; GENE CONTROL; HUMAN; LOW DRUG DOSE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; RISK FACTOR; RISK REDUCTION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ADMINISTRATION, ORAL; ADOLESCENT; AGE FACTORS; ANIMALS; ANTIOXIDANTS; CARCINOGENS; CELL DIFFERENTIATION; CHEMOPREVENTION; DIET; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; GENISTEIN; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MOLECULAR STRUCTURE; PREGNANCY; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SEXUAL MATURATION; SOY FOODS; STILBENES; WINE;

EID: 33846113880     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.6.12.1699     Document Type: Article

References (47)

1. American Cancer Society. Cancer Facts and Figures 2006. American Cancer Society, Atlanta, GA, USA (2006).
2. Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol. Biomarkers Prev. 4 (5), 567-571 (1995).
3. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet 337, 1197-1200 (1991).
4. Wu AH, Ziegler RG, Horn-Ross PL et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol. Biomarkers Prev. 5, 901-906 (1996).
5. Ziegler RG, Hoover RN, Hildeshein RN et al. Migration patterns and breast cancer risk in Asian-American women. J. Natl Cancer Inst. 85, 1819-1827 (1993).
6. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur. J. Endocrinol. 138, 619-620 (1998).
7. Boice JD, Monson RR. Breast cancer in women after repeated fluoroscopic examinations of the chest. J. Natl Cancer Inst. 59, 823-832 (1977).
8. Land CE, McGregor DH. Breast cancer incidence among atomic bomb survivors: implications for radiobiologic risk at low doses. J. Natl Cancer Inst. 62, 17-21 (1979).
9. MacMahon B, Cole P, Brown J. Endocrinology and epidemiology of breast cancer. J. Natl Cancer Inst. 50, 21-42 (1973).
10. Russo J, Russo I. Biology of disease: biological and molecular bases of mammary carcinogenesis. Lab. Invest. 57, 112-137 (1987).
11. Grubbs CJ, Hill DL, McDonough KC, Peckman JC. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells. J. Natl Cancer Inst. 71, 625-628 (1983).
12. Grubbs C J, Farnell DR, Hill DL, McDonough KC. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17β-estradiol and progesterone. J. Natl Cancer Inst. 74, 927-931 (1985).
13. Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252-4263 (1998).
14. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann. Med. 29, 95-120 (1997).
15. Sarkar FH, Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev. 21, 265-280 (2002).
16. Barnes S, Lamartiniere CA. The role of phytoestrogens as cancer prevention agents. In: Cancer Chemoprevention, Volume 1. Kelloff GJ, Hawk ET, Sigman CC (Eds). Humana Press Inc., NJ, USA, 359-369 (2003).
17. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210 (1993).
18. Lamartiniere CA, Moore JB, Brown NM et al. Genistein suppresses mammary cancer in rats. Carcinogenesis 16, 2833-2840 (1995).
19. Fritz WA, Coward L, Wang J. Lamartiniere CA. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19(12), 2151-2158 (1998).
20. Lamartiniere CA. Timing of exposure and mammary cancer risk. J. Mammary Gland Biol. Neoplasia 7 (1), 67-76 (2002).
21. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J. Nutr. 132(3), 552S-558S (2002).
22. Hilakivi-Clarke L, Onojafe I, Raygada M et al. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer 80, 1682-1688 (1999).
23. Badger TM, Ronis MJ, Hakkak R, Rowlands JC, Korourian S. The health consequences of early soy consumption. J. Nutr. 132, 559S-565S (2002).
24. Lubet RL, Steele VE, Barnes S et al. Chemopreventive effects of genistein on methylnitrosourea (MNU)-induced mammary tumors. Proc. Am. Assoc. Cancer Res. 41, 845 (2000).
25. Anderson JJB, Anthony M, Messina M, Garner SC. Effects of phyto-oestrogens on tissues. Nutr. Res. Rev. 12, 75-116 (1999).
26. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 61, 5045-5050 (2001).
27. Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 131, 2957-2962 (2001).
28. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58, 3833-3838 (1998).
29. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer 27, 271-275 (1996).
30. Mizunuma H, Kanazawa K, Ogura S, Otsuka S, Nagai H. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer. Lab. Invest. 62, 78-84 (2002).
31. Jin ZM, MacDonald RS. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J. Nutr. 132, 3186-3190 (2002).
32. Shu XO, Jin F, Dai Q et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev. 10(5), 483-488 (2001).
33. Russo J, Russo IH. DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J. Natl Cancer Inst. 61, 1451-1459 (1978).
34. Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res. 7(3), 131-142 (2005).
35. Brown NM, Wang J, Cotroneo MS, Zhao YX, Lamartiniere CA. Prepubertal genistein treatment modulates TGF-α, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol. Cell. Endocrinol. 144(1-2), 149-165 (1998).
36. Dave B, Eason RR, Till SR et al. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26(10), 1793-1803 (2005).
37. Cabanes A, Wang M, Olivo S et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25 (5), 741-748 (2004).
38. Rowell C, Carpenter DM, Lamartiniere CA. Chemoprevention of breast cancer, proteomic discovery of genistein action in the rat mammary gland. J. Nutr. 135(12 Suppl.), 2953S-2959S (2005).
39. Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C. Resveratrol and breast cancer risk. J. Cancer Prevention 14, 139-142 (2005).
40. Bhat K, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann. NY Acad. Sci. 957, 210-229 (2002).
41. Le Corre L, Chalabi N, Delort L, Bignon Y-J, Bernard-Gallon DJ. Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol. Nutr. Food Res. 49, 462-471 (2005).
42. Jang M, Cai L, Udeani GO et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275(5297), 218-220 (1997).
43. Bhat KP, Lantvit D, Christov K, Mehta RJ, Moon RC, Pezzuto JM. Estrogenic and antiestrogenic properties of resveratrol in mammary cancer models. Cancer Res. 61, 7456-7463 (2001).
44. Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62, 4945-4954 (2002).
45. Provinciali M, Re F, Donnini A et al. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int. J. Cancer 115(l), 36-45 (2005).
46. Whitsett TG, Carpenter DM, Lamartiniere CA. Resveratrol, but not EGCG, in the diet can suppress DMBA-induced mammary cancer in rats. Carcinogenesis 5 (1), 15 (2006).
47. Zhou J-R, Yu L, Mai Z, Blackburn GL. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int. J. Cancer 108, 8-14 (2004).